Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Oct-Dec;17(4):296-298.
doi: 10.4103/wjnm.WJNM_65_17.

Fluroine-18 fluorodeoxyglucose-positron emission tomography/computer tomography in staging of renal cell carcinoma arising from a native kidney with liver and bone metastasis in a renal transplant patient

Koramadai Karuppusamy Kamaleshwaran  1 , Bharat Rangarajan  2 , Raghi Paramben Jose  1 , Ajit Sugunan Shinto  1
Affiliations
Case Reports

Fluroine-18 fluorodeoxyglucose-positron emission tomography/computer tomography in staging of renal cell carcinoma arising from a native kidney with liver and bone metastasis in a renal transplant patient

Koramadai Karuppusamy Kamaleshwaran et al. World J Nucl Med. 2018 Oct-Dec.

Abstract

Renal cell carcinoma (RCC) of the native kidney accounts for <5% of all malignancies found in transplant recipients. There have been only a few reported cases comprising of few renal transplant patients with RCC of native kidneys due to the relative rarity of the condition. Fluorine-18 Fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) is used in the staging of RCC. Prognosis of metastatic RCC is poor. We report the first case of 55-year-old postrenal transplant recipient diagnosed with RCC of the native kidney with liver and bone metastases imaged using F-18 FDG PET/CT.

Keywords: Fluoride-18 Fluorodeoxyglucose-positron emission tomography/computed tomography; native kidney; renal cell carcinoma; renal transplant.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Whole body Fluroine-18 Fluorodeoxyglucose positron emission tomography/computer tomography showing maximum intensity projection image (a), coronal positron emission tomography/computer tomography (b) showing right native kidney primary renal cell carcinoma, axial positron emission tomography/computer tomography (c) showing liver lesion and axial positron emission tomography/computer tomography (d) showing bone metastasis (arrows)
See this image and copyright information in PMC

References

    1. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant. 2004;4:905–13. - PubMed
    1. Klatte T, Marberger M. Renal cell carcinoma of native kidneys in renal transplant patients. Curr Opin Urol. 2011;21:376–9. - PubMed
    1. Schwarz A, Vatandaslar S, Merkel S, Haller H. Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol. 2007;2:750–6. - PubMed
    1. Goh A, Vathsala A. Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am J Transplant. 2011;11:86–92. - PubMed
    1. Cheung CY, Lam MF, Lee KC, Chan GS, Chan KW, Chau KF, et al. Renal cell carcinoma of native kidney in Chinese renal transplant recipients: A report of 12 cases and a review of the literature. Int Urol Nephrol. 2011;43:675–80. - PMC - PubMed

Publication types